Cancer Survivorship and Late Effects

Cancer survivorship covers the health and life of a person from the time of diagnosis through the balance of life, with particular attention to the long-term and late effects that can follow cancer and its treatment. As treatments have improved and the population of survivors has grown, survivorship has become a recognised phase of cancer care in its own right.

Definition

Cancer survivorship is the experience of living with, through, and beyond a cancer diagnosis; late effects are adverse health consequences of cancer or its treatment that appear or persist months to years after therapy ends.

Scope

This entry covers the concept of survivorship, the distinction between long-term and late effects, the main domains of those effects, and the rationale for structured survivorship care planning and surveillance. It is a reference overview and does not provide individual surveillance schedules, screening regimens, or treatment recommendations.

Core questions

• What is meant by cancer survivorship, and when does it begin?
• How do long-term effects differ from late effects of treatment?
• What domains of health are affected in cancer survivors?
• Why are survivorship care plans and structured follow-up proposed?

Key concepts

• Survivorship as a phase of the cancer continuum
• Long-term versus late effects
• Second malignancies and treatment-related toxicity
• Survivorship care plan
• Risk-stratified follow-up and surveillance
• Transition from oncology to primary care

Mechanisms

Late effects arise because anticancer treatments that destroy or control malignant cells can also injure normal tissues, with consequences that may not become apparent until long after treatment. Examples span cardiovascular injury from certain chemotherapies and chest radiotherapy, endocrine and reproductive effects, neurocognitive changes, second malignancies, and persistent fatigue and psychosocial sequelae. Because effects vary by cancer type, treatment exposure, and age at treatment, survivorship care emphasises risk-stratified surveillance and coordinated follow-up (Runowicz, 2015).

Clinical relevance

With millions of cancer survivors, recognising and monitoring for late effects is an important part of long-term care, and survivorship care plans and guidelines describe how follow-up and surveillance can be organised (Runowicz, 2015; IOM, 2006). This entry summarises these concepts for orientation and is not a basis for individual surveillance or treatment decisions, which depend on a person's specific diagnosis and treatment history.

Epidemiology

The number of people living with a history of cancer has grown substantially with improvements in detection and treatment; survivorship statistics estimate many millions of survivors, a population projected to continue rising, who carry varied long-term and late effects of their disease and treatment (Miller, 2016; Miller, 2019).

Evidence & guidelines

The Institute of Medicine's 2006 report From Cancer Patient to Cancer Survivor: Lost in Transition helped establish survivorship care planning, and professional bodies have since issued disease-specific survivorship guidelines, such as the joint ACS/ASCO breast cancer survivorship care guideline (Runowicz, 2015).

History

Survivorship emerged as a distinct concern in the late twentieth century as cancer survival improved. The Institute of Medicine's 2006 report Lost in Transition framed the gap in care after active treatment and promoted survivorship care plans, after which professional societies developed survivorship guidelines and the field consolidated within oncology.

Debates

How should survivorship follow-up be delivered?

Models range from oncology-led to primary-care-led and shared-care follow-up, and the optimal allocation of responsibility, intensity of surveillance, and use of survivorship care plans remain areas of ongoing discussion.

Key figures

• Patricia Ganz
• Julia Rowland

Seminal works

• iom-2006
• runowicz-2015
• miller-2019

Frequently asked questions

When does cancer survivorship begin?

In the widely used definition, survivorship begins at the time of diagnosis and continues through the balance of a person's life, encompassing treatment, recovery, and long-term follow-up rather than only the period after treatment ends.

What is the difference between a long-term effect and a late effect?

Long-term effects begin during treatment and persist afterwards, whereas late effects are absent or unrecognised during treatment and emerge months or years later.